Literature DB >> 33774732

The lethal heat dose for 50% primary human fibroblast cell death is 48 °C.

Elissa Henderson1, Margaretha Kempf2, Charlotte Yip1, Lisa Davenport3, Emily Jones1, Sara Kong1, Ella Pearson1, Anastasia Kearns1, Leila Cuttle4.   

Abstract

Understanding the effect of heat on skin cells is important for the prevention of burn injury. Knowledge of the heat dose required to kill cells can be used to study the cellular mechanisms involved in thermal injury cell death, to assist with the development of novel burn treatments. In this study, primary human skin dermal fibroblasts were exposed to temperatures from 37 to 54 °C for 1 h and the relative cell viability of heat-treated and control cells was assessed. Cell damage and viability were assessed by light microscopy, MTT assay and live/dead staining. The LD50 for 1 h of heat exposure was 48 °C for primary fibroblasts; and there was evidence that thermal damage to cells begins to occur at 43 °C. This study presents a reproducible method for examining the effect of heat on primary human cells grown in culture on a cellular level and can be used in the future to study the mechanisms behind heat-induced cell death, to inform burn injury prevention efforts and effective post-burn treatment.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Burn; Fibroblasts; Hyperthermia; Pathogenesis; Thermal

Mesh:

Year:  2021        PMID: 33774732     DOI: 10.1007/s00403-021-02217-y

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.033


  19 in total

1.  Rise in temperature causes decreased fitness and higher extinction risks in endemic frogs at high altitude forested wetlands in northern Pakistan.

Authors:  Muhammad Saeed; Muhammad Rais; Russell J Gray; Waseem Ahmed; Ayesha Akram; Sumbul Gill; Ghulam Fareed
Journal:  J Therm Biol       Date:  2020-12-14       Impact factor: 2.902

2.  The role of apoptosis in the response of cells and tumours to mild hyperthermia.

Authors:  B V Harmon; Y S Takano; C M Winterford; G C Gobé
Journal:  Int J Radiat Biol       Date:  1991-02       Impact factor: 2.694

3.  Cytotoxicity testing of silver-containing burn treatments using primary and immortal skin cells.

Authors:  Benjawan Boonkaew; Margit Kempf; Roy Kimble; Leila Cuttle
Journal:  Burns       Date:  2014-04-24       Impact factor: 2.744

4.  Glucocorticoids suppress fibroblast apoptosis in an in vitro thermal injury model.

Authors:  Yoshitaka Matsuura; Kazuo Noda; Shigehiko Suzuki; Katsuya Kawai
Journal:  Burns       Date:  2018-09-22       Impact factor: 2.744

5.  Development of experimental in vitro burn model.

Authors:  Ana Carolina Morais Fernandes; Jerônimo Pereira de França; Silvana Gaiba; Antonio Carlos Aloise; Andrea Fernandes de Oliveira; Andrea Aparecida de Fátima Souza Moraes; Lucimar Pereira de França; Lydia Masako Ferreira
Journal:  Acta Cir Bras       Date:  2014       Impact factor: 1.388

Review 6.  Hyperthermia in cancer therapy: the biological basis and unresolved questions.

Authors:  L E Gerweck
Journal:  Cancer Res       Date:  1985-08       Impact factor: 12.701

7.  Pathological effects of hyperthermia in normal tissues.

Authors:  L F Fajardo
Journal:  Cancer Res       Date:  1984-10       Impact factor: 12.701

Review 8.  Wound repair and regeneration.

Authors:  Geoffrey C Gurtner; Sabine Werner; Yann Barrandon; Michael T Longaker
Journal:  Nature       Date:  2008-05-15       Impact factor: 49.962

9.  Cell death induced in a murine mastocytoma by 42-47 degrees C heating in vitro: evidence that the form of death changes from apoptosis to necrosis above a critical heat load.

Authors:  B V Harmon; A M Corder; R J Collins; G C Gobé; J Allen; D J Allan; J F Kerr
Journal:  Int J Radiat Biol       Date:  1990-11       Impact factor: 2.694

Review 10.  Heat shock response and autophagy--cooperation and control.

Authors:  Karol Dokladny; Orrin B Myers; Pope L Moseley
Journal:  Autophagy       Date:  2015       Impact factor: 16.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.